Appointment of Ben Kruger as Lead independent Non-Executive Director ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings”) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 and its subsidiaries (collectively “Aspen” or “the Group”) Appointment of Ben Kruger as Lead Independent Non-Executive Director The Board of Aspen is pleased to announce that it has appointed Mr Ben Kruger to succeed Mr Roy Andersen as the Lead Independent Non-executive Director with effect from 1 October 2019. As announced on 7 March 2019, Mr Andersen will retire from the Board with effect from 30 September 2019. The Board extends its sincere appreciation to Mr Andersen for his dedicated service to Aspen as Lead Independent Director, chairman of its Remuneration & Nomination Committee and member of its Audit & Risk Committee, roles he has performed with diligence and distinction since 2008. 16 September 2019 Sponsor: Investec Bank Limited Date: 16/09/2019 04:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.
Email this JSE Sens Item to a Friend.